Clinical trial
A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth…
NCT00455884 · Ipsen, Industry · Completed
Key facts
| NCT number | NCT00455884 |
|---|---|
| Title | A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency |
| Official title | International Cooperative Metabolic Study (iNCMS) of NutropinAq® [Somatropin (rDNA Origin) Injection] Replacement Therapy in Adults With Growth Hormone Deficiency |
| Lead sponsor | Ipsen, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Growth Hormone Disorders |
| Enrollment | 546 |
| Start date | Jun 1, 2006 |
| Completion | Dec 1, 2011 |
| First posted | Apr 4, 2007 |
| Last update posted | Jan 14, 2019 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: